Emerging infectious disease is the infectious diseases that have newly emerged in humans, or the disease caused by variants of known pathogens (including new drug resistance mechanisms or pathogenicity). With the globalization on transportation, the spread of emerging infectious diseases has become faster and faster, and the impact of pandemics has become greater and greater. Additionally, most of the emerging infectious diseases are zoonotic infectious diseases. Zinexts Life Science is committed to providing platforms and reagents for the detection of infectious diseases. In addition to the part of human medicine, Zinexts will also focus on extending out technologies to stock veterinary medicine.
Real-PCR and isothermal amplification are our two main technology platforms, and these two technologies have also been widely used in clinical and veterinary fields. Real-PCR can provide quantitative and qualitative detection capabilities with both sensitivity and specificity. In addition to excellent qualitative efficiency, isothermal has a simpler mechanical structure that is more convenient to carry and move to the ground.
